Team

The Team

Jesse Kim

CEO

Jesse is a seasoned serial entrepreneur with over 20 years of experience. He is passionate about helping startups flourish and achieve their full market potential, domestically and internationally. He leverages his deep industry knowledge to empower startups to expand their reach and achieve sustainable growth.

Alexis Lee

Managing Partner

Alexis has over a decade of experience guiding startups through global acceleration programs and market strategies. Her additional eight years in early-stage investment and fund operations provide a deep understanding of how to support new ventures and further strengthen her ability to support their growth. Alexis holds a degree in Life Sciences from the University of Toronto, demonstrating her aptitude for both the scientific and business aspects of innovation.

Partners

Hoonje Cho, PhD

CEO/CTO, ActnerLab

Professional Member of the Presidential Advisory Council on Science and Technology of South Korea

Adjunct Professor, Korea Advanced Institute of Science and Technology (KAIST)

Adjunct Professor, Chungnam National University Medical School

Dr. Hoonje Cho has been leading the Tech Incubator Programs for Startups (TIPS) at ActnerLab since 2015. He is a scientist and innovator who specializes in mentoring startups in biomedical and digital healthcare fields.

Dr. Cho has a deep understanding of both the scientific and startup worlds that can be beneficial in converting ideas into real-world applications. In addition to his entrepreneurship, he teaches at the Graduate School of Bio-Innovation Management at KAIST and Chungnam National University Medical School as an Adjunct Professor.

Advisors

Minho Shong, MD, PhD

CEO, THOR Therapeutics

Professor of Medicine, Korea Advanced Institute of Science and Technology (KAIST)

Dr. Minho Shong is a physician-scientist and a Professor at KAIST. He leads a research group focusing on understanding how mitochondrial dysfunction contributes to various diseases. In 2022, he founded THOR Therapeutics to translate his research into tangible solutions by developing the first-in-class treatment for cancer cachexia patients.

Dr. Shong also dedicated his specialties to researching at the National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). He also served as Professor and Dean at Chungnam National University Medical School and as President of Chungnam National University Hospital.

Page updated

Google Sites

Report abuse